Skip to main content
BrainCited

Uridine Monophosphate para Neurotransmitter Imbalance

C

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusão

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs: None Outcome: None Efeito: None None

População: Dogs with intervertebral disc herniation

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes Efeito: None None

População: LPS-induced inflammatory astrocyte model

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs: None Outcome: None Efeito: None None

População: None

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs: None Outcome: None Efeito: None P = 0.013

População: Healthy adults

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs: None Outcome: Cognitive function Efeito: None None

População: Sprague Dawley rats

Key Statistics

4

Estudos

300

Participantes

Positive

C

Nota

Referenced Papers

Aging and disease 2023 9 citações
Clinical pharmacokinetics 2018 128 citações
Autonomic neuroscience : … 2015 81 citações
European journal of … 2011 16 citações
Annual review of … 2009 141 citações
The European journal … 2007 55 citações
Molecular and chemical … 1996 17 citações
Journal of neuroscience … 1996 16 citações
Behavioural brain research 1995 146 citações
Journal of steroid … 1984 22 citações

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

Limite superior: Not established; well-tolerated up to 1,000 mg/day

Dosagens Estudadas em Pesquisas

Dosagem Duração Efeito N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Neutral --
5 mg/kg 4 weeks Positive --
1 g -- Mixed --
None -- Mixed --
None -- Mixed --

Melhor horário: Morning; synergizes with DHA and choline sources

Safety & Side Effects

Efeitos Colaterais Relatados

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

Interações Conhecidas

  • No significant drug interactions established

Ingestão máxima tolerável: Not established; well-tolerated up to 1,000 mg/day

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Outros ingredientes para Neurotransmitter Imbalance

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.